Teratogenicity and placental transfer of All-trans-, 13-cis-, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice
- 31 August 1989
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 100 (1), 162-176
- https://doi.org/10.1016/0041-008x(89)90099-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Automated Determination of 13-Cis-and All-Trans-Retinoic Acid, Their 4-Oxo-Metabolites and Retinol in Plasma, Amniotic Fluid and Embryo by Reversed-Phase High-Performance Liquid Chromatography with a Precolumn Switching TechniqueJournal of Liquid Chromatography, 1988
- Identification of a receptor for the morphogen retinoic acidNature, 1987
- Developmental effects of isotretinoin and 4‐oxo‐isotretinoin: The role of metabolism in teratogenicityTeratology, 1987
- Saturable Accumulation of Retinoic Acid in Neural and Neural Crest Derived Cells in Early Embryonic DevelopmentDevelopmental Pharmacology and Therapeutics, 1987
- Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: Comparison to the all-trans isomerToxicology and Applied Pharmacology, 1987
- ISOTRETINOIN DYSMORPHIC SYNDROMEThe Lancet, 1984
- VITAMIN A AND RETINOIDS: FROM NUTRITION TO PHARMACOTHERAPY IN DERMATOLOGY AND ONCOLOGYThe Lancet, 1983
- Systemic Mode of Action of Vitamin APublished by Elsevier ,1981
- Cellular Vitamin A Binding ProteinsPublished by Elsevier ,1979
- A Note on the Staining of the Skeleton of Cleared Specimens with Alizarin Red SStain Technology, 1926